Aprea Therapeutics
$34.769876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$34.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.27 (+3.79%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours
Why Robinhood?
You can buy or sell APRE and other stocks, options, ETFs, and crypto commission-free!
About APRE
Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Read More The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA.
Employees
—
Headquarters
Boston, Massachusetts
Founded
2002
Market Cap
730.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
122.54K
High Today
$34.96
Low Today
$32.15
Open Price
$33.38
Volume
81.21K
52 Week High
$53.11
52 Week Low
$15.10
Collections
APRE Earnings
-$5.29
-$3.53
-$1.76
$0.00
Q3 2019
Q4 2019
Estimated
— per share
Actual
-$0.64 per share